Schrodinger/$SDGR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Ticker

$SDGR
Primary listing

Industry

Health Care Technology

Employees

891

ISIN

US80810D1037

Schrodinger Metrics

BasicAdvanced
$1.5B
-
-$2.64
1.84
-

What the Analysts think about Schrodinger

Analyst ratings (Buy, Hold, Sell) for Schrodinger stock.

Bulls say / Bears say

Schrödinger's Q1 2025 revenue increased by 62.7% year-over-year to $59.55 million, surpassing analyst expectations of $54.65 million, indicating strong growth potential. (Nasdaq)
Analyst consensus remains bullish, with 73% recommending a 'Buy' rating and a median 12-month price target of $32.00, suggesting a potential upside of approximately 26.5%. (TickerNerd)
The company is set to present new preclinical data on its investigational inhibitors, SGR-3515 and SGR-4174, at the AACR Annual Meeting 2025, potentially enhancing its drug discovery pipeline. (Finviz)
Schrödinger reported a Q1 2025 net loss of $59.81 million, with an adjusted loss per share of $0.82, missing analyst expectations of a $0.75 loss, raising concerns about profitability. (TradingView)
The company's operating margin stands at -83.63%, indicating significant operational inefficiencies that could impact future financial performance. (Forbes)
Despite revenue growth, Schrödinger has consistently reported quarterly losses, with the latest adjusted loss per share at $0.82, suggesting ongoing challenges in achieving profitability. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

Schrodinger Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Schrodinger Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SDGR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs